Phase II Trial of High-Dose Cisplatin Plus Ifosfamide as First-Line Followed by Carboplatin as Second-Line Treatment in Epithelial Ovarian Carcinoma

By Strauss G.   Lund B.   Hansen M.   Hansen H.H.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 66-70

Elsevier

Access to resources Recommend Favorite

Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer

By                                

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1297-1304

Spandidos Publications

Access to resources Recommend Favorite

Phase I/II Study of Intraperitoneal Floxuridine and Platinums (Cisplatin and/or Carboplatin)

By Muggia F.M.   Jeffers S.   Muderspach L.   Roman L.   Rosales R.   Groshen S.   Safra T.   Morrow C.P.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 290-294

Elsevier

Access to resources Recommend Favorite

Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer

By Gordon A.N.   Hancock K.C.   Matthews C.M.   Messing M.   Stringer C.A.   Doherty M.G.   Teneriello M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 129-135

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Carboplatin and Hexamethylmelamine as Induction Chemotherapy in Advanced Epithelial Ovarian Carcinoma

By Kristensen G.B.   Baekelandt M.   Vergote I.B.   Trope C.  

European Journal of Cancer, Vol. 31, Iss. 11, 1995-10 ,pp. : 1778-1780

Elsevier

Access to resources Recommend Favorite